Gender

Male


Location

delhi


Birthday:

May 23


I am...

Biologist, User of nanotechnology products


My research field or area of interest innanotechnology

pharmaceutical sciences


Interest in...

liposome, nanoparticle, microparticle,control release dosage form


Publication list

Publications (International Journals): Total 2 patent application Filed and 5 publications No of patent application file from Ranbaxy Research Lab 1. In-vitro dissolution method for uniform and sustained release of Olanzapine Priority Application No: 484/DEL/2010 on 4th March 2010 2. In-situ Gel Forming Injectable Depot Liquid Composition of Olanzapine Priority Application No.: IN2745/DEL/2009 No. of paper published 1.Vikas Jain a (M Pharm), S.P. Vyas a (Ph.D), D.V. Kohli a *(Ph.D). Well-defined and potent liposomal hepatitis B vaccines adjuvanted with lipophilic MDP derivatives. Nanomedicine. 2009 Jan 18. 2. Vikas Jain 1, Rajnish Sahu 2, Shailja Misra-Bhattacharya 2, Suresh Prasad Vyas 1, Dharmveer Kohli 1 ‘ Enhancement of T-helper type I immune responses against hepatitis B surface antigen by LPS derivatives adjuvanted liposomes delivery system. J Drug Target 2008, Vol. 16, No. 9, Pages 706-715. 3.Sudheesh MS, Jain V, Shilakari G, Kohli DV ‘Development and characterization of lectin-functionalized vesicular constructs bearing amphotericin B for bio-film targeting’. J Drug Target. 2009 Feb;17(2):148-58. 4.Humoral and cell mediated immune response produced after administration of single shot PLA microsphere. Vinay Saini a, Vikas Jain b , Sudheesh MS, Gour RL, Dixit S, Verma SK, Josep SK, P.K.Murthy c, D.V.Kohli a J Drug Target 2010 Apr 18(3) 212-222 5. Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen . Vinay Saini a, Vikas Jain b, P.K.Murthy c, D.V.Kohli a Int. J of Pharm. 2011, Apr 15;408(1-2):50-7. Epub 2011 Feb 1 Abstracts and Presentation:  Vikas jain, D.V.Kohli. Immunoliposome based Targeted Immunization. Preparation and Characterization. Seminar of Nanotechnology. Deptt. of Pharmaceuticals Sciences Sagar India.  Vikas jain, LPS adjuvanted liposomes for targeted immunization against hepatitis B. Presented paper in M.P. council of Science and Technology for Young Scientist Award at Bhopal.  Best paper award in IPC 2008 for the paper entitled ‘T- cell proliferation , IFN-y ,IL-2, and nitric oxide assay after administration of single shot hepatitis B vaccine formulated with PLGA microsphere. Vinay saini, vikas jain , P.K. Murthy, D.V. Kohli Seminar and symposia attended:  Indian pharmaceutical congress New Delhi.  Symposium on current trends in liposome research in 1999 from Deptt. of Pharmaceuticals Sciences Dr. H.S.Gour University, Sagar.  QIP programme organized by Deptt. of Pharmaceuticals Sciences Dr. H.S.Gour University Sagar in 2006.  Annual symposium in Biochemical sciences in 2002 ,CDRI Lucknow  Symposium on safety concern by CSIR committee in CDRI Lucknow.


Researchgroup, Institute, University, School, Company name

deptt.of pharmaceutical sciences SAGAR UNIVERSITY (central)


Researchgroup, Institute, Company, University, School webpage

https://www.dhsgsu.ac.in/


The network creator will send periodical messages to members - you below to allow us to email you

yes